US2004229207A1PendingUtilityA1
Microbial exopolysaccharide
Priority: Oct 26, 1999Filed: Jun 14, 2004Published: Nov 18, 2004
Est. expiryOct 26, 2019(expired)· nominal 20-yr term from priority
B09C 1/00C12N 1/36C08J 5/18C08B 37/006B09C 1/10C08J 2305/00C12P 19/04C12R 2001/01C12N 1/205A01N 63/20
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated exopolysaccharide that consists of
(a) neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, (b) acidic sugars migrating at the same rate as fucose, and (c) amine sugars migrating at the same rate as glucose and fucose, wherein the sugar ratio of sugars migrating as galactose:fucose:glucose:mannose is about 1:2:3:6.
2 . The exopolysaccharide of claim 1 which is that produced by ATCC No. PTA-2500.
3 . The exopolysaccharide of claim 1 which is in purified form.
4 . A nutrient for plant or animal growth, which comprises the exopolysaccharide of claim 3 .
5 . A plasma expander comprising the exopolysaccharide of claim 1 .
6 . The plasma expander of claim 5 , wherein the exopolysaccharide is produced by ATCC No. PTA-2500.
7 . The plasma expander of claim 5 , which further comprises sodium ion at 100 to 120 mEq/1, calcium ion at about 5 mEq/1, potassium ion at 0 to 3 mEq/1, and magnesium ion at 0 to 0.9 mEq/1.
8 . The plasma expander of claim 5 , which further comprises at least one buffer and a nutrient, and a nutrient.
9 . The plasma expander of claim 8 which further comprises vitamin K.
10 . The plasma expander of claim 8 which further comprises human serum albumin.Join the waitlist — get patent alerts
Track US2004229207A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.